Assessing Increased Mortality Risks of Antipsychotics and Mood Stabilizers in Dementia

An article in January’s American Journal of Psychiatry weighs the relative risk of mortality associated with various antipsychotics and mood stabilizers used in the treatment of 33,604 patients with dementia. An accompanying editorial in the same issue points out that the least risky options were also the least effective in curbing aggression.
Read more
                                            Discuss →

Leave a Reply

Your email address will not be published. Required fields are marked *

*

Please keep comments civil and refrain from personal attacks. Comments that fail to meet this guideline will be removed.